Fivetran
Security and trust center evidence
The leader in automated data movement
Summary
Fivetran has 2 registry-verified rows in the CertReports index, last verified 17 Sep 2026. The strongest row is CSA STAR: STAR Level 1 self-assessment (CAIQ). This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.
Reviewer brief
As of 17 Sep 2026, CSA STAR is listed in csa_star for Fivetran, showing a STAR Level 1 self-assessment (CAIQ) issued 12 Oct 2023. As of 17 Sep 2026, EU-US Data Privacy Framework is listed in dpf for Fivetran, with an active status covering EU-US Certification, SW-US Certification, and UK Extension Certification, originally issued 26 Aug 2018 and expiring 02 Jul 2027. As of 17 Sep 2026, no public evidence found for SOC 2 for Fivetran. As of 17 Sep 2026, no public evidence found for HIPAA for Fivetran. As of 17 Sep 2026, no subprocessor records were found in the evidence provided for Fivetran.
- CSA STAR: listed in csa_star, STAR Level 1 self-assessment (CAIQ), issued 12 Oct 2023 (as of 17 Sep 2026).
- EU-US Data Privacy Framework: listed in dpf, active certification (EU-US, SW-US, UK Extension), issued 26 Aug 2018, expires 02 Jul 2027 (as of 17 Sep 2026).
- SOC 2 and HIPAA: no public evidence found for Fivetran (as of 17 Sep 2026).
Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 17 Sep 2026; it is regenerated whenever a row changes.
Among data platforms vendors
2verified rows
Category median 0, across 87 indexed data platforms vendors. Fivetran has more verified rows than 93 percent of them.
cloud-datadata-integrationdata-pipelineetl
Compare with similar vendors
Pick your own comparisonCompliance grid
Legal artefacts
No DPA, BAA or subprocessor list has been captured from a public page yet. Registry rows above do not depend on this. Check the vendor trust centre.
Subprocessors
No subprocessor list captured yet.
Similar vendors with evidence
Related by product tags and the Data platforms category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.
